Transactions with Unknown Duration for Web Services Patrick Sauter, Ingo Melzer.
EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3...
Transcript of EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3...
![Page 1: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/1.jpg)
Staatliches Gewerbeaufsichtsamt Hannover
EU GMP Requirements
Biological medicinal product forhuman use
Dr. Martin Melzer
GMP Training Course
20-21 October 2009
![Page 2: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/2.jpg)
20.10.2009 Dr. Martin Melzer 2
Staatliches Gewerbeaufsichtsamt Hannover
Dr. Martin Melzer
Pharmacist / GMP Inspector
Tel.: + 49 (0) 511 9096 450
![Page 3: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/3.jpg)
20.10.2009 Dr. Martin Melzer 3
Staatliches Gewerbeaufsichtsamt Hannover
Agenda
� Relevant and legally binding documents� EU GMP Annex 2
- If sterile: Annex 1- If herbal: Annex 7- If human blood/ plasma derived: Annex 14
� European Pharmacopoeia� PIC/ S
![Page 4: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/4.jpg)
20.10.2009 Dr. Martin Melzer 4
Staatliches Gewerbeaufsichtsamt Hannover
EU GMP Annex 2Draft
![Page 5: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/5.jpg)
20.10.2009 Dr. Martin Melzer 5
Staatliches Gewerbeaufsichtsamt Hannover
� Definition
EU GMP Annex 2
![Page 6: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/6.jpg)
20.10.2009 Dr. Martin Melzer 6
Staatliches Gewerbeaufsichtsamt Hannover
EU GMP Annex 2 - Scope
![Page 7: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/7.jpg)
20.10.2009 Dr. Martin Melzer 7
Staatliches Gewerbeaufsichtsamt Hannover
EU GMP Annex 2 – Scope cont.
![Page 8: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/8.jpg)
20.10.2009 Dr. Martin Melzer 8
Staatliches Gewerbeaufsichtsamt Hannover
EU GMP Annex 2
� What is so special about biological products ?� Variability of natural sources� Most likely to be prepared aseptically� Limited purification techniques� Potentially hazardous to men
![Page 9: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/9.jpg)
20.10.2009 Dr. Martin Melzer 9
Staatliches Gewerbeaufsichtsamt Hannover
EU GMP Annex 2
� What are the main considerations ?� Risk to the product
- External contamination which can not be removed / detected- Internal contamination (inactivated products contaminated by
non-inactivated product)� …minimized by means of
- Containment- Clean room: positive pressure- Segregation of products („Dedicated equipment“)- Campaign production
![Page 10: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/10.jpg)
20.10.2009 Dr. Martin Melzer 10
Staatliches Gewerbeaufsichtsamt Hannover
EU GMP Annex 2
� What are the main considerations ?� Risk from the product
- „Biological Safety Level“
� … minimized by means of- Containment- Clean room: negative pressure (surrounded by positive
pressure)- Avoidance of air recirculation- Effective decontamination procedures
![Page 11: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/11.jpg)
20.10.2009 Dr. Martin Melzer 11
Staatliches Gewerbeaufsichtsamt Hannover
EU GMP Annex 2
� Part A – General Guidance
� Part B – Specific Guidance on selected producttypes
![Page 12: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/12.jpg)
20.10.2009 Dr. Martin Melzer 12
Staatliches Gewerbeaufsichtsamt Hannover
EU GMP Annex 2
� Part A – General Guidance� Personnel� Premises and equipment� Animals� Documentation� Production� Starting Materials� Seed lot and cell bank system� Operating principles� Quality control
![Page 13: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/13.jpg)
20.10.2009 Dr. Martin Melzer 13
Staatliches Gewerbeaufsichtsamt Hannover
EU GMP Annex 2
� Part B – Specific Guidance on selected product types� Allergens� Animal immunosera products� Vaccines� Recombinant products� Monoclonal antibody products� Gene therapy products� Somatic and xenogeneic cell therapy products� Transgenic animal products� Transgenic plant products� Tissue engineered products (…under development …)
![Page 14: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/14.jpg)
20.10.2009 Dr. Martin Melzer 14
Staatliches Gewerbeaufsichtsamt Hannover
EU GMP Annex 2
� Catchwords� TSE (transmissible spongiform encephalopathies)� Definition of batch� Traceability� Viral safety
![Page 15: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/15.jpg)
20.10.2009 Dr. Martin Melzer 15
Staatliches Gewerbeaufsichtsamt Hannover
European Pharmacopoeia
� 5.1.7 Viral Safety� 6 General monographs
� i.e. Products with risk of TSE� i.e. vaccines for human use� …
![Page 16: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/16.jpg)
20.10.2009 Dr. Martin Melzer 16
Staatliches Gewerbeaufsichtsamt Hannover
PIC/ S(Pharmaceutical Inspection Convention)
� Inspection of biotechnology manufacturers (AideMémoire) (2007)
![Page 17: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/17.jpg)
20.10.2009 Dr. Martin Melzer 17
Staatliches Gewerbeaufsichtsamt Hannover
Thank you !
![Page 18: EU GMP Requirements Biological medicinal product for human use · 20.10.2009 Dr. Martin Melzer 3 Staatliches Gewerbeaufsichtsamt Hannover Agenda Relevant and legally binding documents](https://reader034.fdocuments.us/reader034/viewer/2022052105/604040afbc52bf298d5aee9b/html5/thumbnails/18.jpg)
20.10.2009 Dr. Martin Melzer 18
Staatliches Gewerbeaufsichtsamt Hannover
Link to documents
� EU GMP http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol4_en.htm
� PIC/ S http://www.picscheme.org/